DE3787864D1 - Karzinoembryonisches Antigen kodierende cDNS. - Google Patents

Karzinoembryonisches Antigen kodierende cDNS.

Info

Publication number
DE3787864D1
DE3787864D1 DE87111168T DE3787864T DE3787864D1 DE 3787864 D1 DE3787864 D1 DE 3787864D1 DE 87111168 T DE87111168 T DE 87111168T DE 3787864 T DE3787864 T DE 3787864T DE 3787864 D1 DE3787864 D1 DE 3787864D1
Authority
DE
Germany
Prior art keywords
nucleic acid
cea
carcinoembryonic antigen
detecting
sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE87111168T
Other languages
English (en)
Other versions
DE3787864T2 (de
Inventor
Thomas R Barnett
James J Elting
Michael E Kamarck
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Corp
Original Assignee
Miles Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Miles Inc filed Critical Miles Inc
Publication of DE3787864D1 publication Critical patent/DE3787864D1/de
Application granted granted Critical
Publication of DE3787864T2 publication Critical patent/DE3787864T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3007—Carcino-embryonic Antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Cell Biology (AREA)
  • Oncology (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
DE87111168T 1986-08-13 1987-08-03 Karzinoembryonisches Antigen kodierende cDNS. Expired - Lifetime DE3787864T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US89636186A 1986-08-13 1986-08-13
US1668387A 1987-02-19 1987-02-19
US6003187A 1987-06-19 1987-06-19

Publications (2)

Publication Number Publication Date
DE3787864D1 true DE3787864D1 (de) 1993-11-25
DE3787864T2 DE3787864T2 (de) 1994-02-10

Family

ID=27360631

Family Applications (1)

Application Number Title Priority Date Filing Date
DE87111168T Expired - Lifetime DE3787864T2 (de) 1986-08-13 1987-08-03 Karzinoembryonisches Antigen kodierende cDNS.

Country Status (12)

Country Link
EP (1) EP0263933B1 (de)
JP (2) JP3253609B2 (de)
AT (1) ATE96168T1 (de)
AU (1) AU598573B2 (de)
DE (1) DE3787864T2 (de)
DK (1) DK173134B1 (de)
ES (1) ES2059330T3 (de)
FI (1) FI873478A (de)
IE (1) IE60279B1 (de)
IL (1) IL83484A (de)
NZ (1) NZ221385A (de)
ZA (1) ZA875951B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5122599A (en) * 1986-08-13 1992-06-16 Molecular Diagnostics, Inc. CDNAS coding for members of the carcinoembryonic antigen family
JP2607492B2 (ja) * 1987-01-14 1997-05-07 サントリー株式会社 ヒト癌胎児性抗原
US4908417A (en) * 1988-05-17 1990-03-13 Sumitomo Chemical Company, Limited Thermosetting resin composition
JPH02107189A (ja) * 1988-05-25 1990-04-19 City Of Hope 癌胎児抗原フラグメント
EP0346702A3 (de) * 1988-06-16 1991-08-28 Miles Inc. Transfizierte Zellinien, die isolierte Gene der karzinoembryonale Antigenfamilie exprimieren
US5200316A (en) * 1990-02-15 1993-04-06 Miles Inc. Immunoassay methods using noncross reactive cea gene family members antibodies
DE69233186T2 (de) * 1991-05-06 2004-06-03 The Government Of The United States Of America As Represented By The Secretary Of National Institute Of Health, Office Of Technology Transfer Karcinoembryonale antigen expremierende rekombinante viren und methoden ihrer anwendung
CA2116640A1 (en) * 1993-03-25 1994-09-26 Alexey Terskikh Carcinoembryonic antigen derivatives
US6001349A (en) * 1995-02-22 1999-12-14 Therion Biologics Corporation Generation of human cytotoxic T-cells specific for carcinoma self-associated antigens and uses thereof
CN100523216C (zh) * 2001-03-02 2009-08-05 匹兹堡大学 Pcr方法
US8119352B2 (en) 2006-06-20 2012-02-21 Cepheld Multi-stage amplification reactions by control of sequence replication times
US8815564B2 (en) 2008-03-14 2014-08-26 Sanofi Pasteur Biologics, Llc Replication-defective flavivirus vaccines and vaccine vectors
KR101615474B1 (ko) 2010-12-16 2016-04-25 제넨테크, 인크. Th2 억제에 관한 진단 및 치료
WO2014140938A2 (en) 2013-03-14 2014-09-18 Centre Hospitalier Universitaire Vaudois Immunological methods

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4180499A (en) * 1971-01-27 1979-12-25 Hoffmann-La Roche Inc. Carcinoembryonic antigens
US4228236A (en) * 1978-05-15 1980-10-14 Northwestern University Process of producing carcinoembryonic antigen
JP2507982B2 (ja) * 1984-04-10 1996-06-19 武田薬品工業株式会社 ヒト癌胎児性抗原反応性モノクロ―ナル抗体の製造法

Also Published As

Publication number Publication date
ZA875951B (en) 1988-02-19
AU598573B2 (en) 1990-06-28
EP0263933B1 (de) 1993-10-20
DK420487D0 (da) 1987-08-12
FI873478A0 (fi) 1987-08-11
IL83484A (en) 1993-01-31
IL83484A0 (en) 1988-01-31
FI873478A (fi) 1988-02-14
AU7686887A (en) 1988-03-24
ATE96168T1 (de) 1993-11-15
IE60279B1 (en) 1994-06-29
IE872161L (en) 1988-02-13
EP0263933A1 (de) 1988-04-20
DK420487A (da) 1988-02-14
JPH09136900A (ja) 1997-05-27
DE3787864T2 (de) 1994-02-10
JP3253609B2 (ja) 2002-02-04
DK173134B1 (da) 2000-01-31
JPS63119681A (ja) 1988-05-24
NZ221385A (en) 1991-06-25
ES2059330T3 (es) 1994-11-16

Similar Documents

Publication Publication Date Title
EP0346710A3 (de) cDNAs, die für Mitglieder der Karzinoembryonalantigen-Familie kodieren
DE3787864D1 (de) Karzinoembryonisches Antigen kodierende cDNS.
DK108589A (da) Chimere antistoffer rettet mod humant carcinoembryonalt antigen samt dna-sekvenser, der koder for saadanne antistoffer
NL300197I1 (de)
DK73483A (da) Dna-sekvenser, rekombinant-dna-molekyler samt fremgangsmaader til fremstilling af human-immune interferonlignende polypeptider
AU5909386A (en) Diagnostic reagents based on unique sequences within the variable region of the t cell receptor and uses thereof
ATE87655T1 (de) Markierer der t-zelle aktivierung.
HK1006854A1 (en) Nucleic acid encoding a t-cell antigen receptor polypeptide
NZ502391A (en) Mammalian cytokine: interleukin-B30 and related reagents
ATE157545T1 (de) Antigene proteine und diese enthaltende impfstoffe zur verhütung von kokzidiose
DK108189A (da) Chimere antistoffer rettet mod humant carcinoembryonalt antigen og metal-chelater samt dna-sekvenser, der koder for saadanne antistoffer
DE3585790D1 (de) Varicella-zoster-virus-dns-sequenzen, diese enthaltende vektoren und wirtzellen, uebereinstimmende polypeptide und diese enthaltende verbindungen.
KR890005270A (ko) 재조합 종두 비루스
GB8501473D0 (en) Cloned dna sequences
ES555124A0 (es) Procedimiento de preparar particulas que contienen secuencias de aminoacidos y que tienen propiedades inmunogenas
EP0293079A3 (de) Chlamydia-Vakzin
EP0293827A3 (de) Probe für Leishmaniosis
DK467888A (da) Fremgangsmaade til fiksering af et antigen eller antistof samt et protein paa en baerer, saaledes overtrukket baerer og dens anvendelse.
FI862382A0 (fi) Nya fenantrenderivat, foerfarande foer framstaellning daerav samt fungicida kompositioner innehaollande dessa.
GR3015074T3 (en) Recombinant treponema hyodysenteriae antigen and uses therefor.
NO871737D0 (no) Rekombinant virus, polypeptid samt dna molekyl med kodingssekvens for dette polypeptid.
NO862242D0 (no) Dna-sekvens, replikerbar ekspresjonsvektor, samt plasmid.
NZ215820A (en) Hepatitis b antigen formed by recombinant dna techniques
DE3677956D1 (de) Verbesserungen an waermegedaemmtem glas.
ATE100110T1 (de) Stlv-iii-verwandte polypeptide, diagnosesysteme und testmethoden.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition